Hybrid Stent with Endoscopic Vacuum Therapy (VACStent) for the treatment of post-Ivor Lewis esophagectomy leaks: The First Italian Experience
Endoscopy · 01.04.2024 · 56 (S 02 S 02) · S399
DOI: 10.1055/s-0044-1783690 ↗Kurz gefasst
Fachartikel in der Zeitschrift Endoscopy, erschienen am 01.04.2024. Verfasst von F. V. Mandarino und 14 weiteren Autor:innen.
Abstract (Originalsprache)
Aims
Endoscopic vacuum therapy (EVT) and covered self-expandable metal stent (c-SEMS) are primary treatments for post-esophagectomy leaks. Although these methods have improved clinical outcomes, they have shown some limitations, including the lack of drainage function in c-SEMS and lumen obstruction in EVT. A new fully covered stent within a polyurethane sponge cylinder (VACStent, Microtech, Germany) merges the mechanism of action of both c-SEMS and EVT. The evidence is still preliminary but promising.
Methods
We conducted a prospective follow-up on the first three consecutive patients with anastomotic leak (AL) after Ivor-Lewis esophagectomy (ILE), treated with VACStent placement from June to September 2023 at San Raffaele Hospital (Milan, Italy). The device was scheduled to be changed every 7 days. The negative pressure of the VACStent was set at -125 mmHg for the first 24 hours, then reduced to -75 mmHg. Technical success was defined as the correct device placement and removal. Clinical success was defined as the AL successful healing at the endoscopic and radiological assessment.
Results
Case 1: a 72-year-old man developed a 5 mm AL on the 21st postoperative day (POD) after ILE, and underwent a first VACStent placement. The endoscopic examination after stent removal showed complete healing of the AL. Case 2: a 78-year-old woman was referred to our unit on POD 16 for a recurrent AL following ILE, which had previously been treated with redo surgery. Endoscopy revealed two ALs, each 5 mm in size. A first VACStent placement was performed. Upon removal, leaks were healed. Case 3: a 65-year-old presented with a 7 mm AL on POD 16 th after ILE. She underwent three consecutive VACStent placements. Due to the lack of endoscopic and clinical improvement, we decided to switch the treatment to a c-SEMS placement. No adverse events (AEs) related to the VACStent were recorded in any of the three cases.
Conclusions
In our initial experience with three patients, the VACStent proved to be a safe and effective technique for treating leaks following IVE. Clinical success was achieved in 2 cases of 3. No adverse events were recorded. Larger perspective studies are needed to further define the role of VACStent in managing dehiscences after upper GI surgery. Publication History Article published online: 15 April 2024 © 2024. European Society of Gastrointestinal Endoscopy. All rights reserved. Georg Thieme Verlag KG Rüdigerstraße 14, 70469 Stuttgart, Germany
Zitieren
APA
Mandarino, F. V., Dell'Anna, G., Laterza, L., Fasulo, E., Barchi, A., Fanti, L., Viale, E., Esposito, D., Verga, M. C., Napolitano, M., Elmore, U., Fuccio, L., Rosati, R., Danese, S., & Azzolini, F. (2024). Hybrid Stent with Endoscopic Vacuum Therapy (VACStent) for the treatment of post-Ivor Lewis esophagectomy leaks: The First Italian Experience. Endoscopy, 56(S 02 S 02), S399. https://doi.org/10.1055/s-0044-1783690
Vancouver
Mandarino FV, Dell'Anna G, Laterza L, Fasulo E, Barchi A, Fanti L, et al. Hybrid Stent with Endoscopic Vacuum Therapy (VACStent) for the treatment of post-Ivor Lewis esophagectomy leaks: The First Italian Experience. Endoscopy. 2024;56(S 02 S 02):S399. doi:10.1055/s-0044-1783690
BibTeX
@article{Mandarino2024,
author = {Mandarino, F. V. and Dell'Anna, G. and Laterza, L. and Fasulo, E. and Barchi, A. and Fanti, L. and Viale, E. and Esposito, D. and Verga, M. C. and Napolitano, M. and Elmore, U. and Fuccio, L. and Rosati, R. and Danese, S. and Azzolini, F.},
title = {Hybrid Stent with Endoscopic Vacuum Therapy (VACStent) for the treatment of post-Ivor Lewis esophagectomy leaks: The First Italian Experience},
journal = {Endoscopy},
year = {2024},
volume = {56},
number = {S 02 S 02},
pages = {S399},
doi = {10.1055/s-0044-1783690}
}
EUVIMED